Spotlight on Quadrivalent Human Papillomavirus(Types 6, 11, 16, 18) Recombinant Vaccine(Gardasil®) in the Prevention of PremalignantGenital Lesions, Genital Cancer, and Genital Warts in Women†

Author： McCormack Paul L.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.25, Iss.5, 2011-10, pp. : 339-343

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human Papillomavirus Quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine (Gardasil ® ): Profile Report

By Siddiqui M. Asif A.   Perry Caroline M.  

BioDrugs, Vol. 20, Iss. 5, 2006-01 ,pp. : 313-316

Adis International

Access to resources Recommend Favorite

Giant genital warts

By  

Clinical Case Reports, Vol. 6, Iss. 2, 2018-02 ,pp. : 444-445

John Wiley & Sons Inc

Access to resources Recommend Favorite

Spotlight on AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix®)†

By McKeage Kate  

BioDrugs, Vol. 25, Iss. 4, 2011-08 ,pp. : 265-269

Adis International

Access to resources Recommend Favorite

Human Papillomavirus Types 16 and 18 Vaccine (Recombinant, AS04 Adjuvanted, Adsorbed) [Cervarix™]: Profile Report

By Keam Susan J.  

BioDrugs, Vol. 22, Iss. 3, 2008-01 ,pp. : 205-208

Adis International

Access to resources Recommend Favorite

A Guide to Immunotherapy of Genital Warts: Focus on Interferon and Imiquimod

By Czelusta A.J.  

BioDrugs, Vol. 11, Iss. 5, 1999-05 ,pp. : 319-332

Adis International

Access to resources Recommend Favorite